Klisyri OverviewTirbanibulin, sold under the brand name Klisyri, is a medication for the treatment of actinic keratosis on the face or scalp. The most common side effects include local skin reactions, application site pruritus, and application site pain. Tirbanibulin was approved for medical use in the United States in December 2020. The U.S. Food and Drug Administration (FDA) ...
Read more Klisyri Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tirbanibulin
Recent Klisyri Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Ointment: 1%
NDC Database Records for Klisyri: (1 result)Sorted by National Drug Code
- 16110-391 Klisyri 10 mg/g Topical Ointment by Almirall, LLC